IVF Limit denied as not FDA-approved for this use by UnitedHealthcare?

The UnitedHealthcare Commercial Medical Policy on Infertility Diagnosis, Treatment, and Fertility Preservation governs IVF coverage and refers medical-necessity reviews to the companion Clinical Guideline titled "Fertility Solutions Medical Necessity Clinical Guideline: Infertility." For purposes of this policy, infertility is defined as the inability to achieve a successful pregnancy due to medical, sexual, or reproductive history; failure to achieve pregnancy after 12 months of regular unprotected intercourse (or after 6 months when the female partner meets specified age or risk criteria). Prior authorization is required for IVF and related services and must be submitted via the UnitedHealthcare Provider Portal, and UHC frequently delegates fertility benefit management to Optum (Optum Fertility Solutions), so Optum-managed plans must route prior auth requests and appeals to Optum rather than standard UHC. Quantity limits depend on the member's specific benefit: some plans require Use of a Center of Excellence and apply a lifetime maximum benefit of $25,000 with a $10,000 prescription drug maximum (administered via CVS/Caremark) , while large-group, fully insured California plans are required to cover up to 3 completed oocyte (egg) retrievals and unlimited embryo transfers per plan year . The guideline restricts IVF in specified circumstances: natural cycle IVF is not indicated after 2 failed natural ART cycle attempts; fresh oocyte retrievals are not indicated when previously frozen M2 oocytes or embryos of at least BB grading quality (or genetically normal if tested) are available, although a fresh cycle is indicated when fewer than 20 previously frozen M2 oocytes are available , and additional infertility treatment such as controlled ovarian stimulation, IUI, or ART is not indicated within 6 months of tubal surgery unless additional infertility factors are identified or tubal compromise recurs . Self-injectable infertility drugs are subject to the member-specific benefit/pharmacy benefit administrator, and ART services (IVF, GIFT, ZIFT, PROST, TET) requested for reasons other than infertility are reviewed case-by-case under the member-specific benefit document.

- **Against benefit-exclusion denials in mandate states:** Cite state mandate language; for California, Health and Safety Code §1374.55 requires large group plans issued, amended, or renewed on or after January 1, 2026 to cover diagnosis and treatment of infertility including a maximum of three completed oocyte retrievals with unlimited embryo transfers per ASRM guidelines, and UnitedHealthcare designated this as a benefit standard effective July 1, 2025. - **Against discriminatory definitions of infertility:** UHC's own policy cites ASRM (2021b/2023), ACOG (2019), CDC (2024), and WHO (2022) definitions and recognizes infertility as the inability to achieve pregnancy due to medical, sexual, or reproductive history — not solely the 12-month-intercourse rule ; same-sex couples and single members qualify under this medical-history definition (further, SB 729 prohibits discrimination in coverage and ends the exclusion of LGBTQ+ people in fertility coverage ). - **Against "insufficient prior step therapy" (no IUI tried):** Per ASRM Committee Opinion on diminished ovarian reserve and per UHC's own guideline, IUI is not always required first — history of three failed IUI cycles is one trigger, "unless medically indicated to go straight" to IVF ; document tubal disease, severe male factor (TMSC <5M), advanced maternal age, or DOR (AMH <1.1 ng/mL or FSH ≥10 mIU/mL per ASRM 2020) as a medical indication to bypass IUI. - **Against denial for "embryo banking" or repeat fresh cycle:** Distinguish from banking; per UHC guideline, embryo cryopreservation is a necessary component of elective single embryo transfer and a vital component of pre-implantation genetic testing given the lag time from biopsy to result reporting , and a fresh cycle is indicated when there are fewer than 20 previously frozen M2 oocytes — submit antral follicle count, AMH, and prior-cycle yield to demonstrate the criteria are met. - **Against fertility-preservation denials for iatrogenic infertility (e.g., chemo, GAHT):** Per the Optum Fertility Solutions guideline, fertility preservation is medically necessary for individuals facing gonadotoxic treatment and is indicated for individuals about to undertake gender-affirming hormone therapy (2024 Expert Panel) ; cite ASCO 2018 fertility-preservation guideline and ASRM Ethics Committee Opinion on fertility preservation for medical indications. - **Against wrong-entity / procedural denial:** Confirm which vendor manages the benefit and resubmit; when the plan is Optum-managed, prior authorization requests and appeals must go to Optum, not standard UHC. Request peer-to-peer review with an Optum reproductive endocrinologist within 72 hours of denial. - **Against quantity-limit denials when fewer than 3 retrievals have been used:** Cite ASRM single-embryo-transfer guidance and the plan's own retrieval allowance; large-group fully insured plans must cover up to 3 completed oocyte retrievals and unlimited embryo transfers per plan year, using single embryo transfer when medically appropriate per ASRM — denials before that threshold contradict the policy.

## Why UnitedHealthcare Denies IVF on a "Not FDA-Approved" Basis

In-vitro fertilization is a surgical and laboratory procedure rather than a drug, so it does not carry FDA approval in the conventional sense. UnitedHealthcare sometimes issues denials framed around the absence of FDA approval when it actually means the specific protocol, add-on technique, or associated medication used during your cycle falls outside what it considers an established, evidence-based treatment. Understanding the precise language of your denial letter is the first step — ask your clinic to clarify exactly which element triggered the "not FDA-approved" finding.

## Why This Denial Is Appealable

FDA approval is a regulatory category designed for drugs and devices; it is not the correct legal standard for evaluating a medical procedure. If your plan covers infertility treatment, it is required to apply its medical-necessity criteria to the actual procedure, not to an inapplicable regulatory label. Leading reproductive-medicine societies publish clinical practice guidelines that define evidence-based standards of care for IVF — your prescriber can speak directly to those standards in a medical-necessity letter.

## Your Federal Appeal Rights

• Internal appeal: Under ACA §2719 and ERISA §503, you have the right to a full-and-fair internal review. File within the timeframe on your denial notice (commonly 180 days).
• External review: If the internal appeal is denied or not resolved in time, you may escalate to an Independent Review Organization (IRO). For non-urgent cases the external-review window is generally around four months from the final adverse determination. Expedited external review (typically 72-hour turnaround) is available when your treating physician certifies that the standard timeline would seriously jeopardize your health.

## Concrete Appeal Steps and Timeline

1. Request the complete denial reason in writing and the full plan medical policy governing infertility/IVF within five business days of receiving the denial. 2. Have your reproductive endocrinologist draft a medical-necessity letter addressing each criterion in UHC's published policy. 3. Compile supporting documentation (see below) and submit the internal appeal packet. 4. Track the clock: UHC must respond to a standard internal appeal within 30 days (pre-service) or 60 days (post-service); expedited appeals within 72 hours. 5. If denied internally, request IRO review immediately — do not wait.

## Documentation to Gather

• Diagnosis records confirming infertility etiology and duration
• Complete infertility workup results (laboratory, imaging, semen analysis) without fabricated thresholds — let the records speak to clinical severity
• History of prior treatments attempted, with dates and outcomes
• Reproductive endocrinologist letter of medical necessity citing applicable professional-society guidelines by name and explaining how your case meets each coverage criterion in UHC's policy
• Relevant surgical or procedural notes if applicable

## Criteria-Mapping Structure

Pull UHC's current published medical policy for infertility/IVF. List every numbered requirement. For each requirement, document the exact chart fact that satisfies it. This one-to-one mapping — policy language on the left, chart evidence on the right — is the most persuasive format for both internal reviewers and an IRO.